课题基金 / 基金详情

Identification of a novel tumor suppressor gene on chromosome arm 18q in human pancreatic caner

Identification of a novel tumor suppressor gene on chromosome arm 18q in human pancreatic caner
人胰腺癌染色体臂 18q 上新型抑癌基因的鉴定
批准号:
18390118
负责人:
HORII Akira
金额:
$9.88万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

HORII Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Loss of 18q is highly frequent in human pancreatic cancer. A tumor suppressor gene, SMAD4, resides in this region, but introduction of this gene inhibit tumor cell growth only in vivo by means of angiogenesis inhibition through ETS. Introduction of chromosome 18, however, inhibit both in vitro and in vivo. Moreover, in most of the early lesions of the pancreatic tumorigeneses, 18q is lost but SMAD4 functions normally. Allelotype analyses on 18q identified a commonly lost region between D18S451 and D18S462. Database search indicated a total of 164 protein coding genes. One of such genes, PMAIP1, was picked up by the microarray analyses. This gene is frequently suppressed in pancreatic cancer. Upregulation of this gene caused suppression of the cell growth in pancreatic cancer cells. On the contrary, siRNA-mediated knockdown of the PMAIP1 stimulated cell growth. Thus, the PMAIP1 gene is one of the candidate tumor suppressor genes for pancreatic cancer.We further performed systematic knockdown studies using siRNAs for all the protein-coding genes in the commonly deleted region. Recovery of the cell growth was monitored and we picked up a total of 13 candidate genes. Further detailed studies are necessary.In the course of these studies, we developed a modified buffer system for ligation. Using this system, we can perform ligations in a cheap, efficient, and rapid manner. A total of 100 ligation reaction can be done within a 10 minutes only spending one dollar for 100 reactions. Thus, we named this method as "Coffee break ligation technique."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2008
期刊: Cancer Sci 99
影响因子: --
作者: [Suzuki A, Shibata T, Shimada Y, Murakami Y, Horii A, Shiratori K, Hirohashi S, Inazawa J, Imoto I]
通讯作者: Imoto I
Genetic diagnosis of pancreatic cancer using whole genome amphlification
利用全基因组扩增进行胰腺癌的基因诊断
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [阿部 忠義、堀井 明, 他]
通讯作者:
Suppressed expression of FBXW7 and contrastive enhanced expression of positive cell cycle regulators human glioma.
人胶质瘤中 FBXW7 的表达受到抑制,而阳性细胞周期调节因子的表达则相反增强。
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Gu Zhaodi、堀井 明, 他]
通讯作者:
DOI: 10.3748/wjg.v13.i34.4593
发表时间: 2007-09-14
期刊: WORLD JOURNAL OF GASTROENTEROLOGY
影响因子: 4.3
作者: [Ishida, Masaharu, Sunamura, Makoto, Horii, Akira]
通讯作者: Horii, Akira
22
    Development of invasion and/or metastasis of pancreatic and lung cancers by controlling S100A4
    • 批准号:
      23590452
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2011
    • 负责人:
      HORII Akira
    • 依托单位:
    New avenue for molecular diagnosis of pancreatic and gynecological cancers
    • 批准号:
      17015003
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $27.78万
    • 财政年份:
      2005
    • 负责人:
      HORII Akira
    • 依托单位:
    Reseearch on Genetic Alterations in the Development and Progression of Human Pancreatic Cancer
    • 批准号:
      12470043
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.5万
    • 财政年份:
      2000
    • 负责人:
      HORII Akira
    • 依托单位:
    Genetic alterations involved in initiation and progression of human cancer
    • 批准号:
      07272204
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $38.21万
    • 财政年份:
      1999
    • 负责人:
      HORII Akira
    • 依托单位:
    海外基金